Bjørn Gunnar Iversen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bjørn Gunnar Iversen has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
M. Yelewa
Public Health Institute of Malawi, Ministry of Health, Malawi
2 shared publications- T.M. Arnesen
Public Health Institute of Malawi, Ministry of Health, Malawi; Norwegian Institute of Public Health, Norway
2 shared publications A. Mwale
Public Health Institute of Malawi, Ministry of Health, Malawi
1 shared publicationA. Rahman-Shepherd
National University of Singapore, Singapore
1 shared publicationA. Siddiqua
Public Health Agency Canada, Canada and McMaster University, Canada
1 shared publication- A. Wilson
UK Health Security Agency, UK
1 shared publication
Latest Publications
- Open Access
- 2 July 2026
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 6 (7) , e0006787
Science, policy and trust: Lessons and future strategies for health crisis management in Norway
- 2 July 2026
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 6 (7) , e0006787
Open AccessScience, policy and trust: Lessons and future strategies for health crisis management in Norway
- Open Access
Personal protective effect of wearing surgical face masks in public spaces on self-reported respiratory symptoms in adults: pragmatic randomised superiority trial
Objective To evaluate the personal protective effects of wearing versus not wearing surgical face masks in public spaces on self-reported respiratory symptoms over a 14 day period. Design Pragmatic randomised superiority trial. Setting Norway. Participants 4647 adults aged ≥18 years: 2371 were assigned to the intervention arm and 2276 to the control arm. Interventions Participants in the intervention arm were assigned to wear a surgical face mask in public spaces (eg, shopping centres, streets, public transport) over a 14 day period (mask wearing at home or work was not mentioned). Participants in the control arm were assigned to not wear a surgical face mask in public places. Main outcome measures The primary outcome was self-reported respiratory symptoms consistent with a respiratory infection. Secondary outcomes included self-reported and registered covid-19 infection. Results Between 10 February 2023 and 27 April 2023, 4647 participants were randomised of whom 4575 (2788 women (60.9%); mean age 51.0 (standard deviation 15.0) years) were included in the intention-to-treat analysis: 2313 (50.6%) in the intervention arm and 2262 (49.4%) in the control arm. 163 events (8.9%) of self-reported symptoms consistent with respiratory infection were reported in the intervention arm and 239 (12.2%) in the control arm. The marginal odds ratio was 0.71 (95% confidence interval (CI) 0.58 to 0.87; P=0.001) favouring the face mask intervention. The absolute risk difference was −3.2% (95% CI −5.2% to −1.3%; PConclusion Wearing a surgical face mask in public spaces over 14 days reduces the risk of self-reported symptoms consistent with a respiratory infection, compared with not wearing a surgical face mask. Trial registration ClinicalTrials.gov NCT05690516.
Open AccessPersonal protective effect of wearing surgical face masks in public spaces on self-reported respiratory symptoms in adults: pragmatic randomised superiority trial
Objective To evaluate the personal protective effects of wearing versus not wearing surgical face masks in public spaces on self-reported respiratory symptoms over a 14 day period. Design Pragmatic randomised superiority trial. Setting Norway. Participants 4647 adults aged ≥18 years: 2371 were assigned to the intervention arm and 2276 to the control arm. Interventions Participants in the intervention arm were assigned to wear a surgical face mask in public spaces (eg, shopping centres, streets, public transport) over a 14 day period (mask wearing at home or work was not mentioned). Participants in the control arm were assigned to not wear a surgical face mask in public places. Main outcome measures The primary outcome was self-reported respiratory symptoms consistent with a respiratory infection. Secondary outcomes included self-reported and registered covid-19 infection. Results Between 10 February 2023 and 27 April 2023, 4647 participants were randomised of whom 4575 (2788 women (60.9%); mean age 51.0 (standard deviation 15.0) years) were included in the intention-to-treat analysis: 2313 (50.6%) in the intervention arm and 2262 (49.4%) in the control arm. 163 events (8.9%) of self-reported symptoms consistent with respiratory infection were reported in the intervention arm and 239 (12.2%) in the control arm. The marginal odds ratio was 0.71 (95% confidence interval (CI) 0.58 to 0.87; P=0.001) favouring the face mask intervention. The absolute risk difference was −3.2% (95% CI −5.2% to −1.3%; PConclusion Wearing a surgical face mask in public spaces over 14 days reduces the risk of self-reported symptoms consistent with a respiratory infection, compared with not wearing a surgical face mask. Trial registration ClinicalTrials.gov NCT05690516.
- Open Access
- 10 February 2024
- Published by Elsevier in Public Health
- Vol. 228, 100-104
Factors influencing operationalization of Integrated Disease Surveillance in Malawi
- 10 February 2024
- Published by Elsevier in Public Health
- Vol. 228, 100-104
Open AccessFactors influencing operationalization of Integrated Disease Surveillance in Malawi
- Open Access
- 3 November 2023
- Published by Elsevier in Public Health
- Vol. 225, 141-146
The state of integrated disease surveillance in seven countries: a synthesis report
- 3 November 2023
- Published by Elsevier in Public Health
- Vol. 225, 141-146
Open AccessThe state of integrated disease surveillance in seven countries: a synthesis report